EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+8.73%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.22B
AUM Growth
+$1.22B
(+47%)
Cap. Flow
+$338M
Cap. Flow
% of AUM
27.68%
Top 10 Holdings %
Top 10 Hldgs %
49.95%
Holding
96
New
33
Increased
24
Reduced
16
Closed
17
Top Buys
| 1 |
ARK Genomic Revolution ETF
ARKG
|
$71.6M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$32.8M |
| 3 |
Community Health Systems
CYH
|
$32.4M |
| 4 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
$26.5M |
| 5 |
Amneal Pharmaceuticals
AMRX
|
$24.1M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$23.6M |
| 2 |
The Ensign Group
ENSG
|
$16.9M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$12.3M |
| 4 |
HSKA
Heska Corp
HSKA
|
$11M |
| 5 |
RAD
Rite Aid Corporation
RAD
|
$9.78M |
Sector Composition
| 1 | Healthcare | 92.79% |
| 2 | Consumer Discretionary | 0.09% |
| 3 | Financials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$311M
| $105M | 7.89% | 16,896,796 +952,881 | +6% | +$5.92M |
|
2
United Therapeutics
UTHR
$13.8B
| $81.4M | 6.12% | 486,529 +27,893 | +6% | +$4.67M |
|
|
3
ARK Genomic Revolution ETF
ARKG
$1.04B
| $71.6M | 5.38% | +806,932 | New | +$71.6M |
|
|
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $71.3M | 5.36% | 465,983 +89,783 | +24% | +$13.7M |
|
|
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $64M | 4.81% | 695,459 +164,483 | +31% | +$15.1M |
|
6
Teva Pharmaceuticals
TEVA
$21.1B
| $50.3M | 3.78% | 4,354,756 +1,606,506 | +58% | +$18.5M |
|
7
AstraZeneca
AZN
$248B
| $49.3M | 3.71% | 992,315 +139,884 | +16% | +$6.96M |
|
8
Ascendis Pharma
ASND
$11.8B
| $40.2M | 3.02% | 311,867 +124,824 | +67% | +$16.1M |
|
9
Danaher
DHR
$147B
| $40M | 3.01% | 177,534 +51,204 | +41% | +$11.5M |
|
10
TG Therapeutics
TGTX
$4.65B
| $36.8M | 2.76% | 762,589 -101,262 | -12% | -$4.88M |
|
|
XLRN
11
DELISTED
Acceleron Pharma Inc.
XLRN
| $32.8M | 2.47% | +241,981 | New | +$32.8M |
|
|
12
Community Health Systems
CYH
$387M
| $32.5M | 2.45% | 2,405,834 +2,393,029 | +18,688% | +$32.4M |
|
|
13
Amneal Pharmaceuticals
AMRX
$3B
| $32M | 2.41% | 4,755,480 +3,577,327 | +304% | +$24.1M |
|
14
GSK
GSK
$79.9B
| $31.1M | 2.33% | 852,206 -94,375 | -10% | -$3.44M |
|
15
Envista
NVST
$3.52B
| $29.9M | 2.25% | 732,684 -128,671 | -15% | -$5.25M |
|
16
Avantor
AVTR
$9.18B
| $27.7M | 2.09% | 958,987 +38,337 | +4% | +$1.11M |
|
|
OCDX
17
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $26.5M | 1.99% | +1,375,228 | New | +$26.5M |
|
18
Fate Therapeutics
FATE
$120M
| $26.5M | 1.99% | 321,760 -77,739 | -19% | -$6.41M |
|
19
McKesson
MCK
$85.4B
| $24M | 1.8% | +122,983 | New | +$24M |
|
20
Elevance Health
ELV
$71.8B
| $22.9M | 1.72% | 63,892 -1,879 | -3% | -$674K |
|
21
Qiagen
QGEN
$10.1B
| $22.1M | 1.66% | 454,721 +117,859 | +35% | +$5.74M |
|
|
CTLT
22
DELISTED
CATALENT, INC.
CTLT
| $17.2M | 1.29% | 163,114 -116,389 | -42% | -$12.3M |
|
23
Becton Dickinson
BDX
$55.3B
| $16.6M | 1.25% | +68,383 | New | +$16.6M |
|
|
BHVN
24
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $16.6M | 1.24% | 242,172 +138,408 | +133% | +$9.46M |
|
25
HCA Healthcare
HCA
$94.5B
| $16.1M | 1.21% | 85,409 +68,655 | +410% | +$12.9M |
|